Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy
Clinical trial NCT01404949 · COMPLETED
Trial details
- NCT number
- NCT01404949
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2021-02-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.